Navigation Links
Photo: Scientists Complete Genome Sequence of Fungus Responsible for Dandruff, Skin Disorders
Date:11/5/2007

Research Findings to Impact Human Health, Agricultural Science

CINCINNATI, Nov. 5 /PRNewswire-USNewswire/ -- Today, scientists from P&G Beauty announced that they successfully sequenced the complete genome for Malassezia globosa (M. globosa), a naturally occurring fungus responsible for the onset of dandruff and other skin conditions in humans. Results of the genome sequencing are published in today's online edition of Proceedings of the National Academy of Sciences (PNAS). Dandruff and seborrheic dermatitis affect more than 50 percent of the human population. Despite the role of Malassezia in these and other common skin diseases, including eczema, atopic dermatitis and psoriasis, little was known about the fungus at the molecular level until this study. In addition, understanding of Malassezia's genetic make-up may help scientists reevaluate the parameters that have historically been used to classify fungal organisms.

To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/spectrumscience/30363/

M. globosa, which is among the smallest of the sequenced free-living fungal organisms, is comprised of just around 4,285 genes - roughly 300 times fewer base pairs than are found in the human genome. A common fungus that lives on the skin of humans, M. globosa feeds off of fatty external lipids. Humans naturally secrete sebum and other lipids onto the scalp, creating a prime environment for M. globosa to thrive. The average human can host to up to 10 million M. globosa. Symptoms of dandruff and seborrheic dermatitis occur when three factors come together: genetic susceptibility for an inflammatory response, the presence of sebum on the scalp and the presence of M. globosa.

"A complete genomic sequencing of a Malassezia genome opens tremendous opportunities for researchers to understand the interactions of fungi and humans," said Thomas Dawson, Ph.D., a scientist at P&G Beauty and the principal author of the PNAS study. "It's amazing that the understanding of the genetic make-up of a microscopic organism can have broad implications ranging from human health to agricultural science."

Research and Treatment Implications

The family of Malassezia species affects a wide range of human health issues. While M. globosa is related to a host of irritant conditions, other types of Malassezia have been found to be particularly threatening to individuals with early and compromised immune systems, including infants and those suffering from autoimmune diseases. This fungus family also plays a role in skin and respiratory allergies.

Beyond human health, these findings have agricultural implications. M. globosa is also very closely related to multiple common plant pathogenic fungi that cause disease on corn, wheat, and other important food source crops. Comparative genomic studies are now underway that could lead to new strategies for managing these related crop diseases.

"What started as an effort to unlock the mechanism behind dandruff has opened the scientific doors for the development and enhancement of treatments for dandruff and many more Malassezia-related conditions," said James Schwartz, Ph.D. and Research Fellow at P&G Beauty. "These advances were made possible through collaboration among multiple institutions and subject experts, and we're excited that our findings may benefit multiple disciplines and specialties."

Malassezia is a culprit in conditions mild to severe, but almost nothing was understood at the molecular level before this research. The genetic sequencing of M. globosa has expanded the range of potential treatment targets from a few observational characteristics to now more than 4,000 molecular targets.

Science Behind the Sequencing

The genomic sequencing was made possible by DNA sequencing technologies developed within the last decade. Scientists previously tested many different compounds in a "trial and error" style to find ways to treat and reduce dandruff symptoms. In fact, due to the earlier use of less-accurate culture-based technologies, scientists incorrectly assumed for years that dandruff and seborrheic dermatitis were caused by a different type of fungus (Malassezia furfur). With the use of molecular science, the team uncovered the correct fungal species that was the primary cause of dandruff, eventually leading to the complete sequencing.

For more information on the sequencing of the M. globosa genome or about P&G Beauty, please visit http://www.pgbeautyscience.com/dandruff-genome.html.

P&G Beauty products help make beauty dreams real and grooming enjoyable everyday for millions of women and men worldwide. With more than 100 brands available in nearly 130 countries, P&G Beauty delivered sales of more than $22 billion in fiscal year 2006/07, making it a leading global beauty company. P&G Beauty offers trusted brands with leading technology to meet the full complement of beauty and grooming needs, including Pantene(R), Olay(R), Head and Shoulders(R), Max Factor(R), Cover Girl(R), DDF(R), Sassoon Professional(R), Wellaflex(R), Rejoice(R), Sebastian Professional(R), Herbal Essences(R), Koleston(R), Clairol Professional(R), Nice 'n Easy(R), Venus(R), Gillette(R), SK-II(R), Wella Professionals(R), Christina Aguilera fragrance, Escada(R), Hugo(R), Boss(R) and Lacoste(R) fragrances. Please visit http://www.pg.com for the latest news and in-depth information about P&G (NYSE: PG) and its brands.


'/>"/>
SOURCE P&G Beauty
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Photo: Tanger Outlet Center Shoppers Nationwide can Choose Pink to Fight Breast Cancer
2. Photo: Kyphon and the X-STOP(R) IPD(R) Procedure to be Featured on American Health Radio on Monday, September 24, 2007
3. Video and Photo: Leading CEOs Launch Alliance With American Red Cross to Strengthen Nations Preparedness for Disasters
4. Video and Photo: U.S. Department of Health & Human Services and Ad Council Join NFL to Combat Childhood Obesity
5. Photo: Introducing a New Line of Baby and Toddler Shirts that Can Help Protect Innocent Babies During Flu Season
6. Video and Photo: Tasigna(R) Receives US Approval Providing New Hope to Chronic Myeloid Leukemia Patients With Resistance or Intolerance to Existing Therapies
7. Photo: New York Goes Orange for Pumpkin Festival and Lupus Awareness Month
8. New prion protein discovered by Canadian scientists may offer insight into mad cow disease
9. Scientists Probe Sepsis Deadly Secrets
10. Scientists puzzled by severe allergic reaction to cancer drug in the middle Southern US
11. Scientists Develop Natural Protection for Stored Foods
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... 12, 2017 , ... CitiDent and San Francisco dentists, Dr. ... Oventus O2Vent technology. As many as 18 million Americans are estimated to suffer ... Oral appliances can offer significant relief to about 75 percent of people with ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed a ... and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been ... standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, ...
(Date:10/12/2017)... MD (PRWEB) , ... October 12, 2017 , ... The ... of Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual ... – 8. , In honor of Morris F. Collen, a pioneer in the field ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... delivery system that we intend to develop to enable prevention of a major ... to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader in ... 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced ... 2017. , The annual award competition recognizes editorial and design excellence across a range ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017 The Rebound mobile ... the struggle to reverse the tide of prescription drug addiction. ... regulating their medicine intake and stepping down their dosage in ... to launch in December 2017; the first 100,000 people to ... more at http://www.rebound-solution.com/ ...
(Date:9/25/2017)... Sept. 25, 2017   Montrium , an ... solutions, today—from the IQPC Trial Master Files & ... NL)—announced that EastHORN Clinical Services has selected ... and TMF management. EastHORN, a leading European contract ... to increase transparency to enable greater collaboration with ...
(Date:9/19/2017)... medical device company developing a non-invasive, robotically assisted, platform therapy that uses pulsed sound energy ... ... Jim Bertolina, PhD ... Tom Tefft ... executive Josh Stopek , PhD, who has led R&D and business development teams at ...
Breaking Medicine Technology: